Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 167684, 9 pages
http://dx.doi.org/10.1093/ecam/neq004
Original Article

Antidiabetic Activities of Abutilon indicum (L.) Sweet Are Mediated by Enhancement of Adipocyte Differentiation and Activation of the GLUT1 Promoter

1Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, 2407 River Drive, Knoxville, TN 37996, USA
2Department of Physiology, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
3Department of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand

Received 20 August 2009; Accepted 1 January 2010

Copyright © 2011 Chutwadee Krisanapun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips, “Systematic review of herbs and dietary supplements for glycemic control in diabetes,” Diabetes Care, vol. 26, no. 4, pp. 1277–1294, 2003. View at Publisher · View at Google Scholar
  2. S. Samane, J. Noël, Z. Charrouf, H. Amarouch, and P. S. Haddad, “Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. P. Vollenweider, “Insulin resistant states and insulin signaling,” Clinical Chemistry and Laboratory Medicine, vol. 41, no. 9, pp. 1107–1119, 2003. View at Publisher · View at Google Scholar · View at PubMed
  4. T.-P. Liu, C.-S. Lee, S.-S. Liou, I.-M. Liu, and J.-T. Cheng, “Improvement of insulin resistance by Acanthopanax senticosus root in fructose-rich chow-fed rats,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 8, pp. 649–654, 2005. View at Publisher · View at Google Scholar · View at PubMed
  5. C.-C. Shih, C.-H. Lin, W.-L. Lin, and J.-B. Wu, “Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats,” Journal of Ethnopharmacology, vol. 123, no. 1, pp. 82–90, 2009. View at Publisher · View at Google Scholar · View at PubMed
  6. P. S. Haddad, G. A. Azar, S. Groom, and M. Boivin, “Natural health products, modulation of immune function and prevention of chronic diseases,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 4, pp. 513–520, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. W. Aekplakorn, R. P. Stolk, B. Neal et al., “The prevalence and management of diabetes in Thai adults: the International Collaborative Study of Cardiovascular Disease in Asia,” Diabetes Care, vol. 26, no. 10, pp. 2758–2763, 2003. View at Publisher · View at Google Scholar
  8. A. M. Gray, Y. H. A. Abdel-Wahab, and P. R. Flatt, “The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro,” Journal of Nutrition, vol. 130, no. 1, pp. 15–20, 2000. View at Google Scholar
  9. A. A. Odetola, O. Akinloye, C. Egunjobi, W. A. Adekunle, and A. O. Ayoola, “Possible antidiabetic and antihyperlipidaemic effect of fermented Parkia biglobosa (JACQ) extract in alloxan-induced diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 808–812, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. Y. N. Seetharam, G. Chalageri, S. R. Setty, and Bheemachar, “Hypoglycemic activity of Abutilon indicum leaf extracts in rats,” Fitoterapia, vol. 73, no. 2, pp. 156–159, 2002. View at Publisher · View at Google Scholar
  11. C. Krisanapun, P. Peungvicha, R. Temsiririrkkul, and Y. Wongkrajang, “Aqueous extract of Abutilon indicum Sweet inhibits glucose absorption and stimulates insulin secretion in rodents,” Nutrition Research, vol. 29, no. 8, pp. 579–587, 2009. View at Publisher · View at Google Scholar · View at PubMed
  12. W. Chuakul, P. Saralamp, W. Paonil, R. Temsiririrkkul, and T. Clayton, Medical Plants in Thailand, vol. II, Amarin, Bangkok, Thailand, 1997.
  13. A. Abdul Rahuman, G. Gopalakrishnan, P. Venkatesan, and K. Geetha, “Isolation and identification of mosquito larvicidal compound from Abutilon indicum (Linn.) Sweet,” Parasitology Research, vol. 102, no. 5, pp. 981–988, 2008. View at Publisher · View at Google Scholar · View at PubMed
  14. S. S. Deokule and M. W. Patale, “Pharmacognostic study of Abutilon indicum, (L.) Sweet,” Journal of Phytological Research, vol. 15, pp. 1–6, 2002. View at Google Scholar
  15. E. Porchezhian and S. H. Ansari, “Hepatoprotective activity of Abutilon indicum on experimental liver damage in rats,” Phytomedicine, vol. 12, no. 1-2, pp. 62–64, 2005. View at Publisher · View at Google Scholar
  16. J. Parekh and S. Chanda, “Antibacterial and phytochemical studies on twelve species of Indian medicinal plants,” African Journal of Biomedical Research, vol. 10, pp. 175–181, 2007. View at Google Scholar
  17. M. Ahmed, S. Amin, M. Islam, M. Takahashi, E. Okuyama, and C. F. Hossain, “Analgesic principle from Abutilon indicum,” Pharmazie, vol. 55, no. 4, pp. 314–316, 2000. View at Google Scholar
  18. K. R. Kohli, G. Shilin, and S. A. Kolhapure, “Evaluation of the clinical efficacy and safety of Diabecon in NIDDM,” The Antiseptic, vol. 101, pp. 487–494, 2004. View at Google Scholar
  19. S. K. Mitra, S. Gopumadhavan, T. S. Muralidhar, S. D. Anturlikar, and M. B. Sujatha, “Effect of a herbomineral preparation D-400 in streptozotocin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 54, no. 1, pp. 41–46, 1996. View at Publisher · View at Google Scholar
  20. A. R. Kishan, M. Ajitha, and K. Rajanarayana, “Antidiabetic, antihyperlipidemic and free radical scavenging activities of an Ayurvedic medicine,” Indian Drugs, vol. 37, no. 3, pp. 130–132, 2000. View at Google Scholar
  21. M. Bhat, S. K. Kothiwale, A. R. Tirmale, S. Y. Bhargava, and B. N. Joshi, “Antidiabetic properties of Azardiracta indica and Bougainvillea spectabilis: in vivo studies in murine diabetes model,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar · View at PubMed
  22. P. Peungvicha, S. S. Thirawarapan, R. Temsiririrkkul, H. Watanabe, J. Kumar Prasain, and S. Kadota, “Hypoglycemic effect of the water extract of Piper sarmentosum in rats,” Journal of Ethnopharmacology, vol. 60, no. 1, pp. 27–32, 1998. View at Publisher · View at Google Scholar
  23. A. O. Abdel-Zaher, S. Y. Salim, M. H. Assaf, and R. H. Abdel-Hady, “Antidiabetic activity and toxicity of Zizyphus spina-christi leaves,” Journal of Ethnopharmacology, vol. 101, no. 1–3, pp. 129–138, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. S.-H. Lee, K. Yamaguchi, J.-S. Kim et al., “Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner,” Carcinogenesis, vol. 27, no. 5, pp. 972–981, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. F. Sanchez de Medina, M. J. Gamez, I. Jimenez, J. Jimenez, J. I. Osuna, and A. Zarzuelo, “Hypoglycemic activity of juniper 'berries',” Planta Medica, vol. 60, no. 3, pp. 197–200, 1994. View at Publisher · View at Google Scholar
  26. W. Shang, Y. Yang, L. Zhou, B. Jiang, H. Jin, and M. Chen, “Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes,” Journal of Endocrinology, vol. 198, no. 3, pp. 561–569, 2008. View at Publisher · View at Google Scholar · View at PubMed
  27. J. Lee and M.-S. Kim, “The role of GSK3 in glucose homeostasis and the development of insulin resistance,” Diabetes Research and Clinical Practice, vol. 77, no. 3, pp. S49–S57, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. H. Yki-Järvinen, “Thiazolidinediones,” The New England Journal of Medicine, vol. 351, no. 11, pp. 1106–1158, 2004. View at Publisher · View at Google Scholar · View at PubMed
  29. H. Zhang, H. Matsuda, S. Nakamura, and M. Yoshikawa, “Effects of amide constituents from pepper on adipogenesis in 3T3-L1 cells,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 11, pp. 3272–3277, 2008. View at Publisher · View at Google Scholar · View at PubMed
  30. C. Kausch, J. Krützfeldt, A. Witke et al., “Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells,” Biochemical and Biophysical Research Communications, vol. 280, no. 3, pp. 664–674, 2001. View at Publisher · View at Google Scholar · View at PubMed
  31. F. Chiarelli and D. Di Marzio, “Peroxisome proliferator-activated receptor-γ agonists and diabetes: current evidence and future perspectives,” Vascular Health and Risk Management, vol. 4, no. 2, pp. 297–304, 2008. View at Google Scholar
  32. A. J. Krentz and C. J. Bailey, “Oral antidiabetic agents: current role in type 2 diabetes mellitus,” Drugs, vol. 65, no. 3, pp. 385–411, 2005. View at Publisher · View at Google Scholar
  33. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar
  34. K. Hatao, K. Kaku, M. Matsuda, M. Tsuchiya, and T. Kaneko, “Sulfonylurea stimulates liver fructose-2,6-bisphosphate formation in proportion to its hypoglycemic action,” Diabetes Research and Clinical Practice, vol. 1, pp. 49–53, 1985. View at Google Scholar
  35. M. Matsuda, K. Kaku, and T. Kaneko, “Regulation of muscle fructose 2, 6-bisphosphate levels by sulfonylureas,” Endocrinologia Japonica, vol. 33, no. 6, pp. 913–917, 1986. View at Google Scholar
  36. E. Tsiani, T. Ramlal, L. A. Leiter, A. Klip, and I. G. Fantus, “Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide,” Endocrinology, vol. 136, no. 6, pp. 2505–2512, 1995. View at Google Scholar
  37. E. D. Rosen and B. M. Spiegelman, “Molecular regulation of adipogenesis,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 145–171, 2000. View at Publisher · View at Google Scholar · View at PubMed
  38. S. R. Farmer, “Transcriptional control of adipocyte formation,” Cell Metabolism, vol. 4, no. 4, pp. 263–273, 2006. View at Publisher · View at Google Scholar · View at PubMed
  39. M. Hassan, C. E. Yazidi, J.-F. Landrier, D. Lairon, A. Margotat, and M.-J. Amiot, “Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 1, pp. 208–213, 2007. View at Publisher · View at Google Scholar · View at PubMed
  40. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe, “Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1784–1792, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. J. J. Díez and P. Iglesias, “The role of the novel adipocyte-derived hormone adiponectin in human disease,” European Journal of Endocrinology, vol. 148, no. 3, pp. 293–300, 2003. View at Publisher · View at Google Scholar
  42. S. J. Robins, “PPARα ligands and clinical trials: cardiovascular risk reduction with fibrates,” Journal of Cardiovascular Risk, vol. 8, no. 4, pp. 195–201, 2001. View at Publisher · View at Google Scholar
  43. B. Staels and J.-C. Fruchart, “Therapeutic roles of peroxisome proliferator-activated receptor agonists,” Diabetes, vol. 54, no. 8, pp. 2460–2470, 2005. View at Publisher · View at Google Scholar
  44. P. R. Shepherd and B. B. Kahn, “Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus,” The New England Journal of Medicine, vol. 341, no. 4, pp. 248–257, 1999. View at Publisher · View at Google Scholar
  45. G. I. Shulman, “Cellular mechanisms of insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 2, pp. 171–176, 2000. View at Google Scholar
  46. N. Takahashi, M. Nagamine, S. Tanno, W. Motomura, Y. Kohgo, and T. Okumura, “A diacylglycerol kinase inhibitor, R59022, stimulates glucose transport through a MKK3/6-p38 signaling pathway in skeletal muscle cells,” Biochemical and Biophysical Research Communications, vol. 360, no. 1, pp. 244–250, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. Y. Yamamoto, Y. Yoshimasa, M. Koh et al., “Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expression and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes,” Diabetes, vol. 49, no. 3, pp. 332–339, 2000. View at Google Scholar
  48. S. H. Kim, E.-J. Shin, E.-D. Kim, T. Bayaraa, S. C. Frost, and C.-K. Hyun, “Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes,” Biological and Pharmaceutical Bulletin, vol. 30, no. 11, pp. 2120–2125, 2007. View at Publisher · View at Google Scholar
  49. N. Liu, L. Y. Jia, and Q. S. Sun, “Chemical constituents of Abutilon indicum (L.) Sweet,” Journal of Shenyang Pharmaceutical University, vol. 26, pp. 196–197, 2009. View at Google Scholar
  50. J. Chen, J. Liu, L. Zhang et al., “Pentacyclic triterpenes. Part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 11, pp. 2915–2919, 2006. View at Publisher · View at Google Scholar · View at PubMed